These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27557043)

  • 21. Tetrahydrofolate increases suspension growth of dihydrofolate reductase-deficient chinese hamster ovary DG44 cells in chemically defined media.
    Kim BG; Park HW
    Biotechnol Prog; 2016 Nov; 32(6):1539-1546. PubMed ID: 27578320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel orbital shake bioreactors for transient production of CHO derived IgGs.
    Stettler M; Zhang X; Hacker DL; De Jesus M; Wurm FM
    Biotechnol Prog; 2007; 23(6):1340-6. PubMed ID: 17914862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very high cell density perfusion of CHO cells anchored in a non-woven matrix-based bioreactor.
    Zhang Y; Stobbe P; Silvander CO; Chotteau V
    J Biotechnol; 2015 Nov; 213():28-41. PubMed ID: 26211737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategy for selecting disposable bags for cell culture media applications based on a root-cause investigation.
    Wood J; Mahajan E; Shiratori M
    Biotechnol Prog; 2013; 29(6):1535-49. PubMed ID: 23970490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternating flow filtration as an alternative to internal spin filter based perfusion process: Impact on productivity and product quality.
    Bosco B; Paillet C; Amadeo I; Mauro L; Orti E; Forno G
    Biotechnol Prog; 2017 Jul; 33(4):1010-1014. PubMed ID: 28445603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of orbitally-shaken and stirred-tank bioreactors: pH modulation and bioreactor type affect CHO cell growth and protein glycosylation.
    Monteil DT; Juvet V; Paz J; Moniatte M; Baldi L; Hacker DL; Wurm FM
    Biotechnol Prog; 2016 Sep; 32(5):1174-1180. PubMed ID: 27453130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.
    Kim BJ; Zhao T; Young L; Zhou P; Shuler ML
    Biotechnol Bioeng; 2012 Jan; 109(1):137-45. PubMed ID: 21965160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of high intensity fed-batch mammalian cell cultures in disposable bioreactor systems.
    Smelko JP; Wiltberger KR; Hickman EF; Morris BJ; Blackburn TJ; Ryll T
    Biotechnol Prog; 2011; 27(5):1358-64. PubMed ID: 21626722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular weight and concentration of dextran sulfate affect cell growth and antibody production in CHO cell cultures.
    Hyoung Park J; Sin Lim M; Rang Woo J; Won Kim J; Min Lee G
    Biotechnol Prog; 2016 Sep; 32(5):1113-1122. PubMed ID: 27114230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the impact of high Pluronic® F68 concentrations on antibody producing CHO cell lines.
    Tharmalingam T; Goudar CT
    Biotechnol Bioeng; 2015 Apr; 112(4):832-7. PubMed ID: 25384465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of disposable reactors to generate inoculum cultures for E. coli production fermentations.
    Mahajan E; Matthews T; Hamilton R; Laird MW
    Biotechnol Prog; 2010; 26(4):1200-3. PubMed ID: 20730774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells.
    Dreesen IA; Fussenegger M
    Biotechnol Bioeng; 2011 Apr; 108(4):853-66. PubMed ID: 21404259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell culture media impact on drug product solution stability.
    Purdie JL; Kowle RL; Langland AL; Patel CN; Ouyang A; Olson DJ
    Biotechnol Prog; 2016 Jul; 32(4):998-1008. PubMed ID: 27111574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a new bioprocess scheme using frozen seed train intermediates to initiate CHO cell culture manufacturing campaigns.
    Seth G; Hamilton RW; Stapp TR; Zheng L; Meier A; Petty K; Leung S; Chary S
    Biotechnol Bioeng; 2013 May; 110(5):1376-85. PubMed ID: 23242970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More similar than different: Host cell protein production using three null CHO cell lines.
    Yuk IH; Nishihara J; Walker D; Huang E; Gunawan F; Subramanian J; Pynn AF; Yu XC; Zhu-Shimoni J; Vanderlaan M; Krawitz DC
    Biotechnol Bioeng; 2015 Oct; 112(10):2068-83. PubMed ID: 25894672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing performance of semi-continuous cell culture in an ambr15™ microbioreactor using dynamic flux balance modeling.
    Kelly W; Veigne S; Li X; Subramanian SS; Huang Z; Schaefer E
    Biotechnol Prog; 2018 Mar; 34(2):420-431. PubMed ID: 29152911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess.
    Gao Y; Ray S; Dai S; Ivanov AR; Abu-Absi NR; Lewis AM; Huang Z; Xing Z; Borys MC; Li ZJ; Karger BL
    Biotechnol J; 2016 Sep; 11(9):1190-200. PubMed ID: 27213298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of therapeutic antibody candidates derived from mini-pool and clonal cell lines.
    Fan L; Rizzi G; Bierilo K; Tian J; Yee JC; Russell R; Das TK
    Biotechnol Prog; 2017 Nov; 33(6):1456-1462. PubMed ID: 28393481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.